Correlation Between Arcellx and Innovent Biologics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Arcellx and Innovent Biologics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Arcellx and Innovent Biologics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Arcellx and Innovent Biologics, you can compare the effects of market volatilities on Arcellx and Innovent Biologics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Arcellx with a short position of Innovent Biologics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Arcellx and Innovent Biologics.

Diversification Opportunities for Arcellx and Innovent Biologics

-0.36
  Correlation Coefficient

Very good diversification

The 3 months correlation between Arcellx and Innovent is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Arcellx and Innovent Biologics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Innovent Biologics and Arcellx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Arcellx are associated (or correlated) with Innovent Biologics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Innovent Biologics has no effect on the direction of Arcellx i.e., Arcellx and Innovent Biologics go up and down completely randomly.

Pair Corralation between Arcellx and Innovent Biologics

Given the investment horizon of 90 days Arcellx is expected to generate 1.07 times more return on investment than Innovent Biologics. However, Arcellx is 1.07 times more volatile than Innovent Biologics. It trades about 0.1 of its potential returns per unit of risk. Innovent Biologics is currently generating about 0.03 per unit of risk. If you would invest  1,947  in Arcellx on August 25, 2024 and sell it today you would earn a total of  7,097  from holding Arcellx or generate 364.51% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Arcellx  vs.  Innovent Biologics

 Performance 
       Timeline  
Arcellx 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Arcellx are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of fairly conflicting essential indicators, Arcellx showed solid returns over the last few months and may actually be approaching a breakup point.
Innovent Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Innovent Biologics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Arcellx and Innovent Biologics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Arcellx and Innovent Biologics

The main advantage of trading using opposite Arcellx and Innovent Biologics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Arcellx position performs unexpectedly, Innovent Biologics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Innovent Biologics will offset losses from the drop in Innovent Biologics' long position.
The idea behind Arcellx and Innovent Biologics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital